Medicine: Patients with multiple sclerosis show robust T-cell responses to mRNA COVID-19 vaccines
New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment — which depletes the B cells that contribute to the MS attacks — are able to mount robust T-cell responses to the mRNA COVID-19 vaccines, despite having a muted antibody response to the vaccines. Philadelphia, September 17, 2021.-Continuar Leyendo


















